Status:
COMPLETED
Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia
Lead Sponsor:
Jhpiego
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Merck for Mothers
Conditions:
Post-pregnancy Family Planning
Capacity Building of Healthcare Providers
Eligibility:
FEMALE
15-49 years
Phase:
NA
Brief Summary
The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private-for-profit ...
Detailed Description
PPFP Choices is an operations research study seeking to examine the barriers and facilitators in offering a full range of FP methods in the immediate post-pregnancy period in both the public and priva...
Eligibility Criteria
Inclusion
- Kenyan postpartum participant (Enrollment starts at ANC):
- At least 28 weeks pregnant
- Plans to deliver at the study facility
- Aged 15-49 years at enrollment
- Provides voluntary informed consent
- Not planning to relocate in the next 12 months
- Indonesian postpartum participant (Enrollment starts at L\&D):
- In the immediate postpartum period (within 72 hours, prior to leaving the health facility),
- Reported having attended ANC within her 3rd trimester (28-weeks pregnant and later),
- Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
- Provides voluntary informed consent
- Not planning to relocate in the next 12 months
- Kenyan and Indonesian postabortion participants:
- A female in the immediate post-pregnancy treatment phase (within 72 hours in Indonesia, within 48 hours in Kenya, prior to leaving the health facility for treatment of incomplete abortion)
- Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
- Provides voluntary informed consent
- Not planning to relocate in the next 6 months
Exclusion
- Refusal to sign consent form for inclusion in the study
- Post-delivery baby or mother being treated for trauma or in an intensive care unit
Key Trial Info
Start Date :
November 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2020
Estimated Enrollment :
9282 Patients enrolled
Trial Details
Trial ID
NCT03333473
Start Date
November 9 2017
End Date
March 16 2020
Last Update
August 17 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
RSUD Batang
Batang, Central Java, Indonesia, 51215
2
RSU QOlbu Insan Mulia
Batang, Central Java, Indonesia, 51216
3
Puskesmas Subah
Batang, Central Java, Indonesia, 51262
4
Puskesmas Bawang
Batang, Central Java, Indonesia, 51274